- Press Release -

Rockville, Md. The global cutting balloon catheter market is set to exceed US$ 181.6 Mn by 2022 on sluggish growth, according to Fact.MR, as superior alternatives for minimally invasive cardiovascular and endovascular procedures weigh on demand. Underlying need holds up, though, on the back of rising cardiovascular disease and a steady flow of catheter innovation.

Polyurethane devices lead by material, coronary artery procedures dominate use, and hospitals account for most consumption. North America is the leading region, with Europe and Asia Pacific excluding Japan following.

Materials, Indications and Settings

Polyurethane-based cutting balloon catheters hold the largest revenue share by material. By indication, coronary artery disease dominates at around 73% of revenue. On the end-user side, hospitals lead by a wide margin, consuming more than US$ 121 Mn in 2017 and accounting for about 67% of revenue, supported by their concentration of cardiovascular procedures.

North America stays the leading region on the strength of a well-established healthcare sector, rising healthcare awareness and higher spending. Europe holds over 30% of revenue, while Asia Pacific excluding Japan grows steadily, with China and India shaping its prospects.

Innovation Reshapes Demand

The market sits at a crossroads. Continuous research is producing a wider array of catheters, and manufacturers are moving toward multipurpose balloon devices not limited to a single application. That same innovation, by delivering superior alternatives, is what tempers demand for cutting balloon catheters specifically, even as the broader need for cardiovascular intervention grows.

Suppliers and Their Playbook

The field brings together cardiovascular device specialists and large medical technology firms.

• Hexacath, Boston Scientific Corporation, Medtronic Plc., BIOTRONIK SE & Co. KG, Cook Medical Inc., Cardionovum GmbH, Abbott Laboratories, Terumo Corporation, B. Braun Melsungen AG, Cordis Corporation, MicroPort Scientific Corporation, and Meril Life Sciences Pvt Ltd are among the key players in the report.

Reading the Market for Decisions

For device makers, growth favours multipurpose designs and technological enhancement. Investors get a small, specialised market with steady, procedure-led demand. Procurement and hospital teams can plan around coronary applications carrying volume and North America offering the largest opportunity through 2022.

About the Report

Fact.MR's study covers the global cutting balloon catheter market for the 2017 to 2022 forecast period, with segmentation by raw material, indication, end user and region. It sizes each segment, maps the competitive field, and weighs the clinical forces shaping demand. Further detail is available in the cutting balloon catheter market report.

About Fact.MR

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. The firm is known for its syndicated research, custom research and consulting solutions, helping clients make decisions on demand, competition, investment, procurement and future growth.